Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,538 (5,417, 8,096)","49.8% (41.1%, 61.9%)","76.8% (65.1%, 87.1%)","17.3% (10.7%, 24.9%)","95.5% (93.3%, 96.6%)","12.4 (10.3, 15.5)","19.2 (16.3, 21.8)","4.3 (2.7, 6.2)","23.9 (23.3, 24.2)",,,,,
"(p=None, None), q=(None, None), c=0.500)","6,768 (5,630, 8,351)","61.1% (49.0%, 76.6%)","72.7% (59.2%, 84.5%)","15.8% (9.8%, 21.9%)","96.5% (94.1%, 97.7%)","15.3 (12.3, 19.1)","18.2 (14.8, 21.1)","4.0 (2.4, 5.5)","24.1 (23.5, 24.4)","3.6% (0.8%, 7.5%)","23.1% (7.9%, 44.7%)","-5.5% (-9.9%, -2.8%)","-8.6% (-13.8%, -5.3%)","1.0% (-1.4%, 2.7%)"
"(p=None, None), q=(None, None), c=0.750)","6,915 (5,744, 8,465)","62.1% (49.1%, 75.6%)","71.6% (57.4%, 83.6%)","15.2% (9.4%, 21.2%)","96.6% (94.7%, 98.1%)","15.5 (12.3, 18.9)","17.9 (14.4, 20.9)","3.8 (2.3, 5.3)","24.2 (23.7, 24.5)","5.9% (1.4%, 10.8%)","25.0% (8.7%, 44.8%)","-6.9% (-12.0%, -3.7%)","-12.1% (-19.5%, -7.7%)","1.2% (-1.1%, 3.5%)"
"(p=None, None), q=(None, None), c=1.000)","7,088 (5,858, 8,537)","63.3% (49.2%, 78.1%)","70.4% (55.3%, 81.8%)","14.7% (9.0%, 20.4%)","96.6% (95.1%, 97.7%)","15.8 (12.3, 19.5)","17.6 (13.8, 20.5)","3.7 (2.2, 5.1)","24.2 (23.8, 24.4)","8.6% (3.8%, 15.4%)","27.6% (8.0%, 58.8%)","-8.5% (-15.7%, -5.3%)","-15.0% (-24.3%, -7.9%)","1.2% (-0.7%, 3.3%)"
